Reuters |
Pfizer acquires Bamboo Therapeutics to beef up gene therapy arsenal
Reuters Pfizer Inc said it had acquired privately held gene therapy developer Bamboo Therapeutics Inc in a deal worth up to $645 million to boost its presence in the treatment of rare diseases. Research into gene therapy, which aims to insert corrective genes ... Pfizer Aims to Become Industry Leader in Gene Therapy with Acquisition of Bamboo Therapeutics, Inc. Pfizer Acquires Gene Therapy Firm Bamboo for $150 Million |
Pfizer acquires Bamboo Therapeutics to beef up gene therapy arsenal - Reuters
Read More
0 Response to "Pfizer acquires Bamboo Therapeutics to beef up gene therapy arsenal - Reuters"
Post a Comment